Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells

Elena V. Mashalova, Chandan Guha, Namita Roy-Chowdhury, Laibin Liu, Ira J. Fox, Jayanta Roy-Chowdhury, Marshall S. Horwitz

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Hepatocyte transplantation is being evaluated as an alternative to liver transplantation for metabolic support during liver failure and for definitive treatment of inherited liver diseases. However, as with liver transplantation, transplantation of allogeneic hepatocytes requires prolonged immunosuppression with its associated untoward effects. Therefore, we explored strategies for the genetic modification of donor hepatocytes that could eliminate allograft rejection, obviating the need for immunosuppression. Products of early region 3 (AdE3) of the adenoviral genome are known to protect infected cells from immune recognition and destruction. In the present study we showed that immortalized rat hepatocytes that had been stably transduced with AdE3 before transplantation into fully MHC-mismatched rats are protected from allograft rejection. Quantitative real-time PCR analysis showed that a similar number of engrafted AdE3-transfected hepatocytes had survived in syngeneic and allogeneic recipients. AdE3 expression did not reduce expression of MHC class I on the surfaces of donor hepatocytes. Consistent with this, the in vivo cytotoxic cell-mediated alloresponse was attenuated but not abolished in recipients of AdE3-transfected allogeneic hepatocytes. In contrast, graft survival correlated with a marked reduction in cell-surface localization of Fas receptor in the transplanted cells and inhibition of Fas-mediated apoptosis, which are related to the antiapoptotic functions of the AdE3 proteins. CONCLUSION: AdE3 gene products prevent hepatocyte allograft rejection mainly by protecting the cells from the effector limb of the host immune response and could be used as a tool to facilitate allogeneic hepatocyte transplantation.

Original languageEnglish (US)
Pages (from-to)755-766
Number of pages12
JournalHepatology
Volume45
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Allografts
Hepatocytes
Genes
Homologous Transplantation
Liver Transplantation
Immunosuppression
Transplantation
CD95 Antigens
Liver Failure
Graft Survival
Liver Diseases
Real-Time Polymerase Chain Reaction
Extremities
Genome
Apoptosis
Proteins

ASJC Scopus subject areas

  • Hepatology

Cite this

Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells. / Mashalova, Elena V.; Guha, Chandan; Roy-Chowdhury, Namita; Liu, Laibin; Fox, Ira J.; Roy-Chowdhury, Jayanta; Horwitz, Marshall S.

In: Hepatology, Vol. 45, No. 3, 03.2007, p. 755-766.

Research output: Contribution to journalArticle

Mashalova, Elena V. ; Guha, Chandan ; Roy-Chowdhury, Namita ; Liu, Laibin ; Fox, Ira J. ; Roy-Chowdhury, Jayanta ; Horwitz, Marshall S. / Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells. In: Hepatology. 2007 ; Vol. 45, No. 3. pp. 755-766.
@article{1277c444d44a49a2a4e9a40dcd3338c4,
title = "Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells",
abstract = "Hepatocyte transplantation is being evaluated as an alternative to liver transplantation for metabolic support during liver failure and for definitive treatment of inherited liver diseases. However, as with liver transplantation, transplantation of allogeneic hepatocytes requires prolonged immunosuppression with its associated untoward effects. Therefore, we explored strategies for the genetic modification of donor hepatocytes that could eliminate allograft rejection, obviating the need for immunosuppression. Products of early region 3 (AdE3) of the adenoviral genome are known to protect infected cells from immune recognition and destruction. In the present study we showed that immortalized rat hepatocytes that had been stably transduced with AdE3 before transplantation into fully MHC-mismatched rats are protected from allograft rejection. Quantitative real-time PCR analysis showed that a similar number of engrafted AdE3-transfected hepatocytes had survived in syngeneic and allogeneic recipients. AdE3 expression did not reduce expression of MHC class I on the surfaces of donor hepatocytes. Consistent with this, the in vivo cytotoxic cell-mediated alloresponse was attenuated but not abolished in recipients of AdE3-transfected allogeneic hepatocytes. In contrast, graft survival correlated with a marked reduction in cell-surface localization of Fas receptor in the transplanted cells and inhibition of Fas-mediated apoptosis, which are related to the antiapoptotic functions of the AdE3 proteins. CONCLUSION: AdE3 gene products prevent hepatocyte allograft rejection mainly by protecting the cells from the effector limb of the host immune response and could be used as a tool to facilitate allogeneic hepatocyte transplantation.",
author = "Mashalova, {Elena V.} and Chandan Guha and Namita Roy-Chowdhury and Laibin Liu and Fox, {Ira J.} and Jayanta Roy-Chowdhury and Horwitz, {Marshall S.}",
year = "2007",
month = "3",
doi = "10.1002/hep.21525",
language = "English (US)",
volume = "45",
pages = "755--766",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells

AU - Mashalova, Elena V.

AU - Guha, Chandan

AU - Roy-Chowdhury, Namita

AU - Liu, Laibin

AU - Fox, Ira J.

AU - Roy-Chowdhury, Jayanta

AU - Horwitz, Marshall S.

PY - 2007/3

Y1 - 2007/3

N2 - Hepatocyte transplantation is being evaluated as an alternative to liver transplantation for metabolic support during liver failure and for definitive treatment of inherited liver diseases. However, as with liver transplantation, transplantation of allogeneic hepatocytes requires prolonged immunosuppression with its associated untoward effects. Therefore, we explored strategies for the genetic modification of donor hepatocytes that could eliminate allograft rejection, obviating the need for immunosuppression. Products of early region 3 (AdE3) of the adenoviral genome are known to protect infected cells from immune recognition and destruction. In the present study we showed that immortalized rat hepatocytes that had been stably transduced with AdE3 before transplantation into fully MHC-mismatched rats are protected from allograft rejection. Quantitative real-time PCR analysis showed that a similar number of engrafted AdE3-transfected hepatocytes had survived in syngeneic and allogeneic recipients. AdE3 expression did not reduce expression of MHC class I on the surfaces of donor hepatocytes. Consistent with this, the in vivo cytotoxic cell-mediated alloresponse was attenuated but not abolished in recipients of AdE3-transfected allogeneic hepatocytes. In contrast, graft survival correlated with a marked reduction in cell-surface localization of Fas receptor in the transplanted cells and inhibition of Fas-mediated apoptosis, which are related to the antiapoptotic functions of the AdE3 proteins. CONCLUSION: AdE3 gene products prevent hepatocyte allograft rejection mainly by protecting the cells from the effector limb of the host immune response and could be used as a tool to facilitate allogeneic hepatocyte transplantation.

AB - Hepatocyte transplantation is being evaluated as an alternative to liver transplantation for metabolic support during liver failure and for definitive treatment of inherited liver diseases. However, as with liver transplantation, transplantation of allogeneic hepatocytes requires prolonged immunosuppression with its associated untoward effects. Therefore, we explored strategies for the genetic modification of donor hepatocytes that could eliminate allograft rejection, obviating the need for immunosuppression. Products of early region 3 (AdE3) of the adenoviral genome are known to protect infected cells from immune recognition and destruction. In the present study we showed that immortalized rat hepatocytes that had been stably transduced with AdE3 before transplantation into fully MHC-mismatched rats are protected from allograft rejection. Quantitative real-time PCR analysis showed that a similar number of engrafted AdE3-transfected hepatocytes had survived in syngeneic and allogeneic recipients. AdE3 expression did not reduce expression of MHC class I on the surfaces of donor hepatocytes. Consistent with this, the in vivo cytotoxic cell-mediated alloresponse was attenuated but not abolished in recipients of AdE3-transfected allogeneic hepatocytes. In contrast, graft survival correlated with a marked reduction in cell-surface localization of Fas receptor in the transplanted cells and inhibition of Fas-mediated apoptosis, which are related to the antiapoptotic functions of the AdE3 proteins. CONCLUSION: AdE3 gene products prevent hepatocyte allograft rejection mainly by protecting the cells from the effector limb of the host immune response and could be used as a tool to facilitate allogeneic hepatocyte transplantation.

UR - http://www.scopus.com/inward/record.url?scp=33947395299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947395299&partnerID=8YFLogxK

U2 - 10.1002/hep.21525

DO - 10.1002/hep.21525

M3 - Article

VL - 45

SP - 755

EP - 766

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -